Genetic and Molecular Characterization of Phenylketonuria

Phenylketonuria is an autosomal recessive disorder of amino acid metabolism arising from pathogenic variants in the gene encoding phenylalanine hydroxylase. Loss or reduction of enzyme function impairs the conversion of phenylalanine to tyrosine, leading to elevated systemic levels of phenylalanine, neurotoxicity and risk of intellectual disability if untreated. The clinical spectrum ranges from classic phenylketonuria, with severe enzyme deficiency and markedly elevated blood phenylalanine, to milder forms of hyperphenylalaninaemia. Over a thousand distinct variants have been described, including missense and nonsense substitutions, splice-site mutations, small indels and deep intronic alterations that escape routine screening. Structural studies have delineated catalytic and regulatory domains of the enzyme, revealing how substrate binding at an allosteric site stabilises the active dimer. Advances in next-generation sequencing have expanded the mutational catalogue and enabled detailed genotype–phenotype correlation, informing dietary management, cofactor responsiveness and emerging gene-based therapies. Global surveys highlight population-specific hotspots and underscore the need for tailored newborn-screening panels and molecular diagnostics to optimise patient outcomes worldwide.

Research from Nature Portfolio

Recent studies have employed high-throughput sequencing to map the full spectrum of PAH variants in large cohorts, identifying novel alleles and refining the relationship between specific genotypes and clinical severity. In parallel, crystallographic analysis of the regulatory domain of phenylalanine hydroxylase has provided atomic-level insight into phenylalanine-induced dimerisation and allosteric activation. Together, these investigations offer a mechanistic framework for understanding how particular mutations disrupt enzyme assembly or substrate binding, and they lay the groundwork for rational design of small-molecule chaperones and improved cofactor therapies.

Genetic and Molecular Characterization of Phenylketonuria publication trend

The graph below shows the total number of articles in genetic and molecular characterization of phenylketonuria across all publications each year (not limited to Nature Index journals).

Technical terms

Phenylalanine hydroxylase (PAH): An enzyme that catalyses the hydroxylation of phenylalanine to tyrosine, deficiency of which causes phenylketonuria.

Hyperphenylalaninaemia (HPA): Elevated blood phenylalanine concentration, encompassing both classical phenylketonuria and milder forms.

Genotype–phenotype correlation: The relationship between specific genetic variants and the severity or characteristics of the clinical presentation.

Allosteric regulation: Modulation of enzyme activity through binding of a molecule to a site distinct from the catalytic centre, affecting protein conformation and function.

Deep intronic variant: A mutation located within intronic regions far from exon–intron boundaries that can create novel splice sites or alter gene expression.

Next-generation sequencing (NGS): High-throughput technology allowing simultaneous detection of multiple variant types across entire genes or genomes.

References

1. Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene. International Journal of Molecular Sciences (2024).
2. The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China. Human Genomics (2023).
3. Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing. Biomedicines (2023).
4. Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing. Orphanet Journal of Rare Diseases (2023).
5. Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain. Scientific Reports (2016).
6. Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus. PLOS ONE (2018).
7. Analysis of the genotype-phenotype correlation in patients with phenylketonuria in mainland China. Scientific Reports (2018).